Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label,Multicenter Randomised Study of CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for the New Diagnosed Young Patients With T Cell Non-hodgkin Lymphoma

NCT01746992 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT01746992
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01746992 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label,Multicenter Randomised Study of CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for the New Diagnosed Young Patients With T Cell Non-hodgkin Lymphoma
Lead sponsor
Ruijin Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
September 30, 2012
Completion date
December 31, 2018
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alk-negative anaplastic large cell lymphoma, angioimmunoblastic t cell lymphoma, enteropathy associated t cell lymphoma, hepatosplenic t cell lymphoma, peripherial t cell lymphoma,not otherwise specified, subcutaneous panniculitis like t cell lymphoma